<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">35207429</PMID><DateRevised><Year>2022</Year><Month>03</Month><Day>01</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2075-1729</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><Issue>2</Issue><PubDate><Year>2022</Year><Month>Jan</Month><Day>19</Day></PubDate></JournalIssue><Title>Life (Basel, Switzerland)</Title><ISOAbbreviation>Life (Basel)</ISOAbbreviation></Journal><ArticleTitle>The Effects of Persistent Olfactory and Gustatory Dysfunctions on Quality of Life in Long-COVID-19 Patients.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">141</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/life12020141</ELocationID><Abstract><AbstractText>(1) Background: Persistent olfactory (POD) and gustatory (PGD) dysfunctions are one of the most frequent symptoms of long-Coronavirus Disease 2019 but their effect on the quality of life (QoL) of patients is still largely unexplored. (2) Methods: An online survey was administered to individuals who reported to have had SARS-CoV-2 infection at least 6 months prior with persisting COVID-19 symptoms (using the COVID symptom index), including ratings of POD and PGD, and their physical (PCS) and mental (MCS) components of quality of life were assessed using the standardized short form 12 questionnaire (SF-12). (3) Results: Responses from 431 unique individuals were included in the analyses. The most frequent persistent symptoms were: fatigue (185 cases, 42.9%), olfactory dysfunction (127 cases, 29.5%), gustatory dysfunction (96 cases, 22.3%) and muscle pain (83 cases, 19.3%). Respondents who reported persisting muscle pain, joint pain, fatigue, headache, gastrointestinal disturbances, and dyspnea had significantly worse PCS. Those experiencing persistent fatigue and dyspnea also showed significantly lower MCS. Respondents reporting POD or PGD showed significantly worse QoL, but only pertaining to the MCS. Multiple regressions predicted MCS based on olfactory and marginally on gustatory ratings, but not PCS. Age significantly affected the prediction of PCS but not MCS, and gender and temporal distance from the COVID-19 diagnosis had no effect. (4) Conclusions: POD and PGD are frequent symptoms of the long-COVID-19 syndrome and significantly reduce QoL, specifically in the mental health component. This evidence should stimulate the establishment of appropriate infrastructure to support individuals with persistent CD, while research on effective therapies scales up.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Vaira</LastName><ForeName>Luigi Angelo</ForeName><Initials>LA</Initials><Identifier Source="ORCID">0000-0002-7789-145X</Identifier><AffiliationInfo><Affiliation>Maxillofacial Surgery Operative Unit, Department of Medical, Surgical and Experimental Sciences, University of Sassari, 07100 Sassari, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Biomedical Science Department, PhD School of Biomedical Science, University of Sassari, 07100 Sassari, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gessa</LastName><ForeName>Claudia</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-1291-5422</Identifier><AffiliationInfo><Affiliation>Maxillofacial Surgery Operative Unit, Department of Medical, Surgical and Experimental Sciences, University of Sassari, 07100 Sassari, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Deiana</LastName><ForeName>Giovanna</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0003-1151-6830</Identifier><AffiliationInfo><Affiliation>Direction, Hygiene and Hospital Infection Control Operative Unit, Department of Medical, Surgical and Experimental Sciences, University of Sassari, 07100 Sassari, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Salzano</LastName><ForeName>Giovanni</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0003-3947-8733</Identifier><AffiliationInfo><Affiliation>Maxillofacial Surgery Department, University Hospital of Naples "Federico II", 80131 Naples, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maglitto</LastName><ForeName>Fabio</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Maxillofacial Surgery Department, University Hospital of Naples "Federico II", 80131 Naples, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lechien</LastName><ForeName>Jerome R</ForeName><Initials>JR</Initials><Identifier Source="ORCID">0000-0002-0845-0845</Identifier><AffiliationInfo><Affiliation>Department of Human and Experimental Oncology, Faculty of Medicine UMONS Research Institute for Health Sciences and Technology, University of Mons (UMons), 7000 Mons, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Otolaryngology-Head &amp; Neck Surgery, Foch Hospital, School of Medicine, UFR Simone Veil, Versailles Saint-Quentin-en-Yvelines University, Paris Saclay University, 91190 Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saussez</LastName><ForeName>Sven</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-3655-1854</Identifier><AffiliationInfo><Affiliation>Department of Human and Experimental Oncology, Faculty of Medicine UMONS Research Institute for Health Sciences and Technology, University of Mons (UMons), 7000 Mons, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Piombino</LastName><ForeName>Pasquale</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-8624-0878</Identifier><AffiliationInfo><Affiliation>Maxillofacial Surgery Department, University Hospital of Naples "Federico II", 80131 Naples, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Biglio</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Maxillofacial Surgery Operative Unit, Department of Medical, Surgical and Experimental Sciences, University of Sassari, 07100 Sassari, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Maxillofacial Surgery Department, San Paolo Hospital, ASST Santi Paolo e Carlo, University of Milan, 20122 Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Biglioli</LastName><ForeName>Federico</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Maxillofacial Surgery Department, San Paolo Hospital, ASST Santi Paolo e Carlo, University of Milan, 20122 Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boscolo-Rizzo</LastName><ForeName>Paolo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Medicine, Surgery and Health Sciences, University of Trieste, 34149 Trieste, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hopkins</LastName><ForeName>Claire</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Guy's and St Thomas NHS Foundation Trust, London SE1 7EH, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>British Rhinological Society (President), London WC2A 3PE, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Parma</LastName><ForeName>Valentina</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Monell Chemical Senses Center, Philadelphia, PA 19104, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychology, Temple University, Philadelphia, PA 19122, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Riu</LastName><ForeName>Giacomo</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Maxillofacial Surgery Operative Unit, Department of Medical, Surgical and Experimental Sciences, University of Sassari, 07100 Sassari, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Biomedical Science Department, PhD School of Biomedical Science, University of Sassari, 07100 Sassari, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>01</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Life (Basel)</MedlineTA><NlmUniqueID>101580444</NlmUniqueID><ISSNLinking>2075-1729</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">ageusia</Keyword><Keyword MajorTopicYN="N">anosmia</Keyword><Keyword MajorTopicYN="N">gustatory disorders</Keyword><Keyword MajorTopicYN="N">long-COVID-19</Keyword><Keyword MajorTopicYN="N">olfactory disorders</Keyword><Keyword MajorTopicYN="N">quality of life</Keyword><Keyword MajorTopicYN="N">smell</Keyword><Keyword MajorTopicYN="N">taste</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>12</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>12</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>1</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>2</Month><Day>25</Day><Hour>1</Hour><Minute>12</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>2</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>2</Month><Day>26</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>1</Month><Day>19</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35207429</ArticleId><ArticleId IdType="pmc">PMC8878431</ArticleId><ArticleId IdType="doi">10.3390/life12020141</ArticleId><ArticleId IdType="pii">life12020141</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Halpin S., O&#x2019;Connor R., Sivan M. Long COVID and chronic COVID syndromes. J. Med. Virol. 2021;93:1242&#x2013;1243. doi: 10.1002/jmv.26587.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26587</ArticleId><ArticleId IdType="pmc">PMC7675759</ArticleId><ArticleId IdType="pubmed">33034893</ArticleId></ArticleIdList></Reference><Reference><Citation>Otte M.S., Bork M.-L., Zimmermann P.H., Klussmann J.P., Luers J.C. Persisting olfactory dysfunction improves in patients 6 months after COVID-19 disease. Acta Oto-Laryngol. 2021;141:626&#x2013;629. doi: 10.1080/00016489.2021.1905178.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/00016489.2021.1905178</ArticleId><ArticleId IdType="pubmed">33823752</ArticleId></ArticleIdList></Reference><Reference><Citation>Lechien J.R., Chiesa-Estomba C.M., Beckers E., Mustin V., Ducarme M., Journe F., Marchant A., Jouffe L., Barillari M.R., Cammaroto G., et al. Prevalence and 6-month recovery of olfactory dysfunction: A multicentre study of 1363 COVID-19 patients. J. Intern. Med. 2021;290:451&#x2013;461. doi: 10.1111/joim.13209.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.13209</ArticleId><ArticleId IdType="pubmed">33403772</ArticleId></ArticleIdList></Reference><Reference><Citation>Bussi&#xe8;re N., Mei J., L&#xe9;vesque-Boissonneault C., Blais M., Carazo S., Gros-Louis F., De Serres G., Dupr&#xe9; N., Frasnelli J. Chemosensory dysfunctions induced by COVID-19 can persist up to 7 months: A study of over 700 healthcare workers. Chem. Senses. 2021;46:bjab038. doi: 10.1093/chemse/bjab038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/chemse/bjab038</ArticleId><ArticleId IdType="pmc">PMC8499810</ArticleId><ArticleId IdType="pubmed">34423831</ArticleId></ArticleIdList></Reference><Reference><Citation>Boscolo-Rizzo P., Menegaldo A., Fabbris C., Spinato G., Borsetto D., Vaira L.A., Calvanese L., Pettorelli A., Sonego M., Frezza D., et al. Six-Month Psychophysical Evaluation of Olfactory Dysfunction in Patients with COVID-19. Chem. Senses. 2021;46:bjab006. doi: 10.1093/chemse/bjab006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/chemse/bjab006</ArticleId><ArticleId IdType="pmc">PMC7929204</ArticleId><ArticleId IdType="pubmed">33575808</ArticleId></ArticleIdList></Reference><Reference><Citation>Riestra-Ayora J., Yanes-Diaz J., Esteban-Sanchez J., Vaduva C., Molina-Quiros C., Larran-Jimenez A., Martin-Sanz E. Long-term follow-up of olfactory and gustatory dysfunction in COVID-19: 6 months case&#x2013;control study of health workers. Eur. Arch. Oto-Rhino-Laryngol. 2021;278:4831&#x2013;4837. doi: 10.1007/s00405-021-06764-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00405-021-06764-y</ArticleId><ArticleId IdType="pmc">PMC8004560</ArticleId><ArticleId IdType="pubmed">33774737</ArticleId></ArticleIdList></Reference><Reference><Citation>Petrocelli M., Cutrupi S., Salzano G., Maglitto F., Salzano A.F., Lechien J.R., Saussez S., Boscolo-Rizzo P., De Riu G., Vaira A.L. Six-month smell and taste recovery rates in coronavirus disease 2019 patients: A prospective psychophysical study. J. Laryngol. Otol. 2021;135:436&#x2013;441. doi: 10.1017/S002221512100116X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S002221512100116X</ArticleId><ArticleId IdType="pmc">PMC8111201</ArticleId><ArticleId IdType="pubmed">33888166</ArticleId></ArticleIdList></Reference><Reference><Citation>Hopkins C., Surda P., Vaira L., Lechien J., Safarian M., Saussez S., Kumar N. Six month follow-up of self-reported loss of smell during the COVID-19 pandemic. Rhinol. J. 2021;59:26&#x2013;31. doi: 10.4193/Rhin20.544.</Citation><ArticleIdList><ArticleId IdType="doi">10.4193/Rhin20.544</ArticleId><ArticleId IdType="pubmed">33320115</ArticleId></ArticleIdList></Reference><Reference><Citation>Niklassen A.S., Draf J., Huart C., Hintschich C., Bocksberger S., Trecca E.M.C., Klimek L., Le Bon S.D., Altundag A., Hummel T. COVID-19: Recovery from Chemosensory Dysfunction. A Multicentre study on Smell and Taste. Laryngoscope. 2021;131:1095&#x2013;1100. doi: 10.1002/lary.29383.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/lary.29383</ArticleId><ArticleId IdType="pubmed">33404079</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaira L.A., Salzano G., Le Bon S.D., Maglio A., Petrocelli M., Steffens Y., Ligas E., Maglitto F., Lechien J.R., Saussez S., et al. Prevalence of Persistent Olfactory Disorders in Patients with COVID-19: A Psychophysical Case-Control Study with 1-Year Follow-up. Otolaryngol. Neck Surg. 2021 doi: 10.1177/01945998211061511.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/01945998211061511</ArticleId><ArticleId IdType="pubmed">34813382</ArticleId></ArticleIdList></Reference><Reference><Citation>Boscolo-Rizzo P., Guida F., Polesel J., Marcuzzo A.V., Antonucci P., Capriotti V., Sacchet E., Cragnolini F., D&#x2019;Alessandro A., Zanelli E., et al. Self-reported smell and taste recovery in coronavirus disease 2019 patients: A one-year prospective study. Eur. Arch. Oto-Rhino-Laryngol. 2022;297:515&#x2013;520. doi: 10.1007/s00405-021-06839-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00405-021-06839-w</ArticleId><ArticleId IdType="pmc">PMC8103884</ArticleId><ArticleId IdType="pubmed">33963433</ArticleId></ArticleIdList></Reference><Reference><Citation>Boscolo-Rizzo P., Hummel T., Hopkins C., Dibattista M., Menini A., Spinato G., Fabbris C., Emanuelli E., D&#x2019;Alessandro A., Marzolino R., et al. High prevalence of long-term olfactory, gustatory, and chemesthesis dysfunction in post-COVID-19 patients: A matched case-control study with one-year follow-up using a comprehensive psychophysical evaluation. Rhinol. J. 2021;59:517&#x2013;527. doi: 10.4193/Rhin21.249.</Citation><ArticleIdList><ArticleId IdType="doi">10.4193/Rhin21.249</ArticleId><ArticleId IdType="pubmed">34553706</ArticleId></ArticleIdList></Reference><Reference><Citation>Lechien J.R., Chiesa-Estomba C.M., Vaira L.A., Saussez S., Hans S. COVID-19 Reinfection and Second Episodes of Olfactory and Gustatory Dysfunctions: Report of First Cases. Ear Nose Throat J. 2020 doi: 10.1177/0145561320970105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0145561320970105</ArticleId><ArticleId IdType="pubmed">33170036</ArticleId></ArticleIdList></Reference><Reference><Citation>Lechien J.R., Chiesa-Estomba C.M., Radulesco T., Michel J., Vaira L.A., Le Bon S.D., Horoi M., Falanga C., Barillari M.R., Hans S., et al. Clinical features of patients who had two COVID-19 episodes: A European multicentre case series. J. Intern. Med. 2021;290:421&#x2013;429. doi: 10.1111/joim.13259.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.13259</ArticleId><ArticleId IdType="pmc">PMC8013656</ArticleId><ArticleId IdType="pubmed">33527495</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaira L.A., De Vito A., Lechien J.R., Chiesa-Estomba C.M., Mayo-Y&#xe0;&#xf1;ez M., Calvo-Henr&#xec;quez C., Saussez S., Madeddu G., Babudieri S., Boscolo-Rizzo P., et al. New Onset of Smell and Taste Loss Are Common Findings Also in Patients with Symptomatic COVID -19 After Complete Vaccination. Laryngoscope. 2022;132:419&#x2013;421. doi: 10.1002/lary.29964.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/lary.29964</ArticleId><ArticleId IdType="pmc">PMC9011575</ArticleId><ArticleId IdType="pubmed">34812498</ArticleId></ArticleIdList></Reference><Reference><Citation>Philpott C., Boak D. The Impact of Olfactory Disorders in the United Kingdom. Chem. Senses. 2014;39:711&#x2013;718. doi: 10.1093/chemse/bju043.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/chemse/bju043</ArticleId><ArticleId IdType="pubmed">25201900</ArticleId></ArticleIdList></Reference><Reference><Citation>Boesveldt S., Parma V. The importance of the olfactory system in human well-being, through nutrition and social behavior. Z. Zellforsch. Mikrosk. Anat. 2021;383:559&#x2013;567. doi: 10.1007/s00441-020-03367-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00441-020-03367-7</ArticleId><ArticleId IdType="pmc">PMC7802608</ArticleId><ArticleId IdType="pubmed">33433688</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan C.H., Faraji F., Bs D.P.P., Ostrander B.T., DeConde A.S. Self-reported olfactory loss associates with outpatient clinical course in COVID-19. Int. Forum Allergy Rhinol. 2020;10:821&#x2013;831. doi: 10.1002/alr.22592.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alr.22592</ArticleId><ArticleId IdType="pmc">PMC7264572</ArticleId><ArticleId IdType="pubmed">32329222</ArticleId></ArticleIdList></Reference><Reference><Citation>Hopkins C., Vaira L.A., De Riu G. Self-reported olfactory loss in COVID-19: Is it really a favorable prognostic factor? Int. Forum Allergy Rhinol. 2020;10:926. doi: 10.1002/alr.22608.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alr.22608</ArticleId><ArticleId IdType="pmc">PMC7272810</ArticleId><ArticleId IdType="pubmed">32395917</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaira L.A., Hopkins C., Petrocelli M., Lechien J.R., Soma D., Giovanditto F. Do olfactory and gustatory psycho-physiocal scores have prognostic value in COVID-19 patients? A prospective study of 106 patients. J. Otolaryngol. Head Neck Surg. 2020;49:56. doi: 10.1186/s40463-020-00449-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40463-020-00449-y</ArticleId><ArticleId IdType="pmc">PMC7406962</ArticleId><ArticleId IdType="pubmed">32762737</ArticleId></ArticleIdList></Reference><Reference><Citation>Speth M.M., Singer-Cornelius T., Oberle M., Gengler I., Brockmeier S.J., Sedaghat A.R. Mood, anxiety and olfactory dys-function in COVID-19: Evidence of central nervous system involvement? Laryngoscope. 2020;130:2520&#x2013;2525. doi: 10.1002/lary.28964.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/lary.28964</ArticleId><ArticleId IdType="pmc">PMC7361512</ArticleId><ArticleId IdType="pubmed">32617983</ArticleId></ArticleIdList></Reference><Reference><Citation>Yom-Tov E., Lekkas D., Jacobson N.C. Association of COVID19-induced anosmia and ageusia with depression and suicidal ideation. J. Affect. Disord. Rep. 2021;5:100156. doi: 10.1016/j.jadr.2021.100156.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jadr.2021.100156</ArticleId><ArticleId IdType="pmc">PMC8154197</ArticleId><ArticleId IdType="pubmed">34075369</ArticleId></ArticleIdList></Reference><Reference><Citation>Croy I., Symmank A., Schellong J., Hummel C., Gerber J., Joraschky P., Hummel T. Olfaction as a marker for depression in humans. J. Affect. Disord. 2014;160:80&#x2013;86. doi: 10.1016/j.jad.2013.12.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jad.2013.12.026</ArticleId><ArticleId IdType="pubmed">24445134</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuland C., Bitter T., Marschner H., Gudziol H., Guntinas-Lichius O. Health-related and specific olfaction-related quality of life in patients with chronic functional anosmia or severe hyposmia. Laryngoscope. 2011;121:867&#x2013;872. doi: 10.1002/lary.21387.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/lary.21387</ArticleId><ArticleId IdType="pubmed">21298638</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamrava S.K., Tavakol Z., Talebi A., Farhadi M., Jalessi M., Hosseini S.F., Amini E., Chen B., Hummel T., Alizadeh R. A study of depression, partnership and sexual satisfaction in patients with post-traumatic olfactory disorders. Sci. Rep. 2021;11:1&#x2013;8. doi: 10.1038/s41598-021-99627-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-99627-9</ArticleId><ArticleId IdType="pmc">PMC8511173</ArticleId><ArticleId IdType="pubmed">34642400</ArticleId></ArticleIdList></Reference><Reference><Citation>Watson D.L.B., Campbell M., Hopkins C., Smith B., Kelly C., Deary V. Altered smell and taste: Anosmia, parosmia and the impact of long COVID-19. PLoS ONE. 2021;16:e0256998. doi: 10.1371/journal.pone.0256998.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0256998</ArticleId><ArticleId IdType="pmc">PMC8462678</ArticleId><ArticleId IdType="pubmed">34559820</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohla K., Tomer Green M.G.V., Hannum M.E., Bakke A.J., Moein S.T., Tognetti A. Increasing incidence of parosmia and phantosmia in patients recovering from COVID-19 smell loss. medRxiv. 2021 doi: 10.1101/2021.08.28.21262763.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.08.28.21262763</ArticleId></ArticleIdList></Reference><Reference><Citation>Saniasiaya J., Prepageran N. Impact of olfactory dysfunction on quality of life in coronavirus disease 2019 patients: A sys-tematic review. J. Laryngol. Otol. 2021;135:947&#x2013;952. doi: 10.1017/S0022215121002279.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0022215121002279</ArticleId><ArticleId IdType="pmc">PMC8438414</ArticleId><ArticleId IdType="pubmed">34425929</ArticleId></ArticleIdList></Reference><Reference><Citation>Alshakhs A., AlMomen A., Alyaeesh I., AlOmairin A., Almutairi A.A., Alammar Z., AlMomen H., AlMomen Z. The association of smell and taste dysfunction with COVID19, and their functional impacts. Indian J. Otolaryngol. Head Neck Surg. 2021:1&#x2013;6. doi: 10.1007/s12070-020-02330-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12070-020-02330-w</ArticleId><ArticleId IdType="pmc">PMC7822753</ArticleId><ArticleId IdType="pubmed">33520687</ArticleId></ArticleIdList></Reference><Reference><Citation>Coelho D.H., Reiter E.R., Budd S.G., Shin Y., Kons Z.A., Costanzo R.M. Quality of life and safety impact of COVID-19 associated smell and taste disturbances. Am. J. Otolaryngol. 2021;42:103001. doi: 10.1016/j.amjoto.2021.103001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjoto.2021.103001</ArticleId><ArticleId IdType="pmc">PMC7983361</ArticleId><ArticleId IdType="pubmed">33773440</ArticleId></ArticleIdList></Reference><Reference><Citation>Elkholi S.M.A., Abdelwahab M.K., Abdelhafeez M. Impact of the smell loss on the quality of life and adopted coping strategies in COVID-19 patients. Eur. Arch. Oto-Rhino-Laryngol. 2021;278:3307&#x2013;3314. doi: 10.1007/s00405-020-06575-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00405-020-06575-7</ArticleId><ArticleId IdType="pmc">PMC7814376</ArticleId><ArticleId IdType="pubmed">33464401</ArticleId></ArticleIdList></Reference><Reference><Citation>Rass V., Beer R., Schiefecker A.J., Kofler M., Lindner A., Mahlknecht P., Heim B., Limmert V., Sahanic S., Pizzini A., et al. Neurological outcome and quality of life 3 months after COVID-19: A prospective observational cohort study. Eur. J. Neurol. 2021;28:3348&#x2013;3359. doi: 10.1111/ene.14803.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.14803</ArticleId><ArticleId IdType="pmc">PMC8250725</ArticleId><ArticleId IdType="pubmed">33682276</ArticleId></ArticleIdList></Reference><Reference><Citation>Coons S.J., Rao S., Keininger D.L., Hays R.D. A Comparative Review of Generic Quality-of-Life Instruments. PharmacoEconomics. 2000;17:13&#x2013;35. doi: 10.2165/00019053-200017010-00002.</Citation><ArticleIdList><ArticleId IdType="doi">10.2165/00019053-200017010-00002</ArticleId><ArticleId IdType="pubmed">10747763</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee D.Y., Lee W.H., Wee J.H., Kim J.-W. Prognosis of Postviral Olfactory Loss: Follow-up Study for Longer than One Year. Am. J. Rhinol. Allergy. 2014;28:419&#x2013;422. doi: 10.2500/ajra.2014.28.4102.</Citation><ArticleIdList><ArticleId IdType="doi">10.2500/ajra.2014.28.4102</ArticleId><ArticleId IdType="pubmed">25198029</ArticleId></ArticleIdList></Reference><Reference><Citation>Malik P., Patel K., Pinto C., Jaiswal R., Tirupathi R., Pillai S. Post-acute COVID-19 syndrome (PCS) and health-related quality of life (HRQoL)&#x2014;A systematic review and meta-analysis. J. Med. Virol. 2022;94:253&#x2013;262. doi: 10.1002/jmv.27309.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27309</ArticleId><ArticleId IdType="pmc">PMC8662132</ArticleId><ArticleId IdType="pubmed">34463956</ArticleId></ArticleIdList></Reference><Reference><Citation>Ware Jr J., Kosinski M., Keller S.D. A 12-item short-form health survey: Construction of scales and preliminary tests of relia-bility and validity. Med. Care. 1996;34:220&#x2013;223. doi: 10.1097/00005650-199603000-00003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00005650-199603000-00003</ArticleId><ArticleId IdType="pubmed">8628042</ArticleId></ArticleIdList></Reference><Reference><Citation>Gandek B., Ware J.E., Aaronson N.K., Apolone G., Bjorner J.B., Brazier J.E., Bullinger M., Kaasa S., Leplege A., Prieto L., et al. Cross-Validation of Item Selection and Scoring for the SF-12 Health Survey in Nine Countries: Results from the IQOLA Project. International Quality of Life Assessment. J. Clin. Epidemiol. 1998;51:1171&#x2013;1178. doi: 10.1016/S0895-4356(98)00109-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0895-4356(98)00109-7</ArticleId><ArticleId IdType="pubmed">9817135</ArticleId></ArticleIdList></Reference><Reference><Citation>COVID-19 e Qualit&#xe0; della Vita.  [(accessed on 8 December 2021)].  Available online:  https://it.surveymonkey.com/r/WSZ7TVS.</Citation></Reference><Reference><Citation>Lechien J.R., Chiesa-Estomba C.M., Hans S., Calvo-Henriquez C., Mayo-Y&#xe1;&#xf1;ez M., Tucciarone M., Vaira L.A., Saussez S., Saibene A.M. Validity and reliability of the COVID-19 symptom index, an instrument evaluating severity of general and otolaryngological symptoms. Acta Oto-Laryngol. 2021;131:615&#x2013;620. doi: 10.1080/00016489.2021.1899282.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/00016489.2021.1899282</ArticleId><ArticleId IdType="pubmed">33733988</ArticleId></ArticleIdList></Reference><Reference><Citation>Kodraliu G., Mosconi P., Groth N., Carmosino G., Perilli A., Gianicolo E.A. Subjective health status assessment: Evaluation of the Italian version of the SF-12 health survey. Results from the MiOS project. J. Epidemiol. Biostat. 2001;6:305&#x2013;316. doi: 10.1080/135952201317080715.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/135952201317080715</ArticleId><ArticleId IdType="pubmed">11437095</ArticleId></ArticleIdList></Reference><Reference><Citation>Vilagut G., Forero C.G., Pinto-Meza A., Haro J.M., de Graaf R., Bruffaerts R., Kovess V., de Girolamo G., Matschinger H., Ferrer M., et al. The Mental Component of the Short-Form 12 Health Survey (SF-12) as a Measure of Depressive Disorders in the General Population: Results with Three Alternative Scoring Methods. Value Health. 2013;16:564&#x2013;573. doi: 10.1016/j.jval.2013.01.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jval.2013.01.006</ArticleId><ArticleId IdType="pubmed">23796290</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaira L.A., Lechien J.R., Khalife M., Petrocelli M., Hans S., Distinguin L., Salzano G., Cucurullo M., Doneddu P., Salzano F.A., et al. Psychophysical Evaluation of the Olfactory Function: European Multicenter Study on 774 COVID-19 Patients. Pathogens. 2021;10:62. doi: 10.3390/pathogens10010062.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens10010062</ArticleId><ArticleId IdType="pmc">PMC7827350</ArticleId><ArticleId IdType="pubmed">33445604</ArticleId></ArticleIdList></Reference><Reference><Citation>Parma V., Ohla K., Veldhuizen M.G., Niv M.Y., Kelly C.E., Bakke A.J., Cooper K.W., Bouysset C., Pirastu N., Dibattista M., et al. More Than Smell&#x2014;COVID-19 Is Associated with Severe Impairment of Smell, Taste, and Chemesthesis. Chem. Senses. 2020;45:609&#x2013;622. doi: 10.1093/chemse/bjaa041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/chemse/bjaa041</ArticleId><ArticleId IdType="pmc">PMC7337664</ArticleId><ArticleId IdType="pubmed">32564071</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaira L.A., Hopkins C., Salzano G., Petrocelli M., Melis A., Cucurullo M., Ferrari M., Gagliardini L., Pipolo C., Deiana G., et al. Olfactory and gustatory function impairment in COVID -19 patients: Italian objective multicenter-study. Head Neck. 2020;42:1560&#x2013;1569. doi: 10.1002/hed.26269.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hed.26269</ArticleId><ArticleId IdType="pmc">PMC7280583</ArticleId><ArticleId IdType="pubmed">32437022</ArticleId></ArticleIdList></Reference><Reference><Citation>Saniasiaya J., Islam M.A., Abdullah B. Prevalence of olfactory dysfunction in coronavirus disease 2019 (COVID-19): A meta-analysis of 27,492 patients. Laryngoscope. 2021;131:865&#x2013;878. doi: 10.1002/lary.29286.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/lary.29286</ArticleId><ArticleId IdType="pmc">PMC7753439</ArticleId><ArticleId IdType="pubmed">33219539</ArticleId></ArticleIdList></Reference><Reference><Citation>Lechien J.R., Chiesa-Estomba C.M., Vaira L.A., De Riu G., Cammaroto G., Chekkoury-Idrissi Y., Circiu M., Distinguin L., Journe F., de Terwangne C., et al. Epidemiological, otolaryngological, olfactory and gustatory outcomes according to the severity of COVID-19: A study of 2579 patients. Eur. Arch. Oto-Rhino-Laryngol. 2021;278:2851&#x2013;2859. doi: 10.1007/s00405-020-06548-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00405-020-06548-w</ArticleId><ArticleId IdType="pmc">PMC7811338</ArticleId><ArticleId IdType="pubmed">33452919</ArticleId></ArticleIdList></Reference><Reference><Citation>Doty R.L. Epidemiology of smell and taste dysfunction. Huntingt. Dis. 2019;164:3&#x2013;13. doi: 10.1016/b978-0-444-63855-7.00001-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/b978-0-444-63855-7.00001-0</ArticleId><ArticleId IdType="pubmed">31604555</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaira A.L., Hopkins C., Petrocelli M., Lechien J.R., Chiesa-Estomba C.M., Salzano G., Cucurullo M., Salzano A.F., Saussez S., Boscolo-Rizzo P., et al. Smell and taste recovery in coronavirus disease 2019 patients: A 60-day objective and prospective study. J. Laryngol. Otol. 2020;134:703&#x2013;709. doi: 10.1017/S0022215120001826.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0022215120001826</ArticleId><ArticleId IdType="pmc">PMC7471571</ArticleId><ArticleId IdType="pubmed">32782030</ArticleId></ArticleIdList></Reference><Reference><Citation>Hannum E.M., Ramirez A.V., Lipson S.J., Herriman R.D., Toskala A.K., Lin C., Joseph P.V., Reed D.R. Objective sensory testing methods reveal a higher prevalence of olfactory loss in COVID-19&#x2013;positive patients compared to subjective methods: A systematic review and meta-analysis. Chem. Senses. 2020;45:865&#x2013;874. doi: 10.1093/chemse/bjaa064.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/chemse/bjaa064</ArticleId><ArticleId IdType="pmc">PMC7543258</ArticleId><ArticleId IdType="pubmed">33245136</ArticleId></ArticleIdList></Reference><Reference><Citation>Lechien J.R., Journe F., Hans S., Chiesa-Estomba C.M., Mustin V., Beckers E., Vaira L.A., De Riu G., Hopkins C., Saussez S. Severity of Anosmia as an Early Symptom of COVID-19 Infection May Predict Lasting Loss of Smell. Front. Med. 2020;7:582802. doi: 10.3389/fmed.2020.582802.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2020.582802</ArticleId><ArticleId IdType="pmc">PMC7732577</ArticleId><ArticleId IdType="pubmed">33330539</ArticleId></ArticleIdList></Reference><Reference><Citation>Petrocelli M., Ruggiero F., Baietti A.M., Pandolfi P., Salzano G., Salzano A.F., Lechien J.R., Saussez S., De Riu G., Vaira A.L. Remote psychophysical evaluation of olfactory and gustatory functions in early-stage coronavirus disease 2019 patients: The Bologna experience of 300 cases. J. Laryngol. Otol. 2020;134:571&#x2013;576. doi: 10.1017/S0022215120001358.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0022215120001358</ArticleId><ArticleId IdType="pmc">PMC7387786</ArticleId><ArticleId IdType="pubmed">32605666</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaira L.A., Salzano G., Petrocelli M., Deiana G., Salzano F.A., De Riu G. Validation of a self-administered olfactory and gustatory test for the remotely evaluation of COVID -19 patients in home quarantine. Head Neck. 2020;42:1570&#x2013;1576. doi: 10.1002/hed.26228.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hed.26228</ArticleId><ArticleId IdType="pmc">PMC7267597</ArticleId><ArticleId IdType="pubmed">32357379</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaira L.A., Lechien J.R., Salzano G., Salzano F.A., Maglitto F., Saussez S., De Riu G. Gustatory Dysfunction: A Highly Specific and Smell-Independent Symptom of COVID-19. Indian J. Otolaryngol. Head Neck Surg. 2020:1&#x2013;3. doi: 10.1007/s12070-020-02182-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12070-020-02182-4</ArticleId><ArticleId IdType="pmc">PMC7524863</ArticleId><ArticleId IdType="pubmed">33014753</ArticleId></ArticleIdList></Reference><Reference><Citation>Le Bon S.D., Horoi M. Is anosmia the price to pay in an immune-induced schorched-earth policy against COVID-19? Med. Hypotheses. 2020;143:109881. doi: 10.1016/j.mehy.2020.109881.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mehy.2020.109881</ArticleId><ArticleId IdType="pmc">PMC7248625</ArticleId><ArticleId IdType="pubmed">32474381</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaira L.A., Salzano G., Fois A.G., Piombino P., De Riu G. Potential pathogenesis of ageusia and anosmia in COVID-19 pa-tients. Int. Forum Allergy Rhinol. 2020;10:1103&#x2013;1104. doi: 10.1002/alr.22593.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alr.22593</ArticleId><ArticleId IdType="pmc">PMC7267531</ArticleId><ArticleId IdType="pubmed">32342636</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang F., Wang D.Y. COVID-19 anosmia: High prevalence, plural neuropathogenic mechanisms, and scarce neurotropism of SARS-CoV-2? Viruses. 2021;13:2225. doi: 10.3390/v13112225.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13112225</ArticleId><ArticleId IdType="pmc">PMC8625547</ArticleId><ArticleId IdType="pubmed">34835030</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaira L.A., Hopkins C., Sandison A., Manca A., Machouchas N., Turilli D., Lechien J.R., Barillari M.R., Salzano G., Cossu A., et al. Olfactory epithelium histopathological findings in long-term coronavirus disease 2019 related anosmia. J. Laryngol. Otol. 2020;134:1123&#x2013;1127. doi: 10.1017/S0022215120002455.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0022215120002455</ArticleId><ArticleId IdType="pmc">PMC7729153</ArticleId><ArticleId IdType="pubmed">33190655</ArticleId></ArticleIdList></Reference><Reference><Citation>De Melo G.D., Lazarini F., Levallois S., Hautefort C., Michel V., Larrous F., Verillaud B., Aparicio C., Wagner S., Gheusi G., et al. COVID-19&#x2013;related anosmia is associated with viral persistence and inflammation in human olfactory epithelium and brain infection in hamsters. Sci. Transl. Med. 2021;13:eabf8396. doi: 10.1126/scitranslmed.abf8396.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abf8396</ArticleId><ArticleId IdType="pmc">PMC8158965</ArticleId><ArticleId IdType="pubmed">33941622</ArticleId></ArticleIdList></Reference><Reference><Citation>Lechien J.R., Michel J., Radulesco T., Chiesa-Estomba C.M., Vaira L.A., De Riu G., Sowerby L., Hopkins C., Saussez S. Clinical and Radiological Evaluations of COVID -19 Patients with Anosmia: Preliminary Report. Laryngoscope. 2020;130:2526&#x2013;2531. doi: 10.1002/lary.28993.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/lary.28993</ArticleId><ArticleId IdType="pmc">PMC7404961</ArticleId><ArticleId IdType="pubmed">32678494</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaira L.A., Lechien J.R., Salzano G., Maglitto F., Saussez S., De Riu G. The role of nasal immunoglobulins in the recovery of olfactory function in COVID-19 patients. Am. J. Otolaryngol. 2021:103301. doi: 10.1016/j.amjoto.2021.103301.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjoto.2021.103301</ArticleId><ArticleId IdType="pmc">PMC8638244</ArticleId><ArticleId IdType="pubmed">34895763</ArticleId></ArticleIdList></Reference><Reference><Citation>Lechien J.R., Radulesco T., Calvo-Henriquez C., Chiesa-Estomba C.M., Hans S., Barillari M.R. ACE2 &amp; TMPRSS2 expressions in head &amp; neck tissues: A systemic review. Head Neck Pathol. 2021;15:225&#x2013;235.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7439628</ArticleId><ArticleId IdType="pubmed">32816230</ArticleId></ArticleIdList></Reference><Reference><Citation>Le Bon S., Payen L., Prunier L., Steffens Y., Horoi M., Vaira L.A., Hopkins C., Lechien J.R., Saussez S. Making scents of loss of taste in COVID-19: Is self-reported loss of taste due to olfactory dysfunction? A prospective study using psychophysical testing. Int. Forum Allergy Rhinol. 2021;11:1504&#x2013;1507. doi: 10.1002/alr.22815.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alr.22815</ArticleId><ArticleId IdType="pmc">PMC8222876</ArticleId><ArticleId IdType="pubmed">34013654</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaira L.A., Deiana G., Lechien J.R., De Vito A., Cossu A., Dettori M. Correlations between olfactory psychophysical scores and SARS-CoV-2 viral load in COVID-19 patients. Laryngoscope. 2021;131:2312&#x2013;2318. doi: 10.1002/lary.29777.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/lary.29777</ArticleId><ArticleId IdType="pmc">PMC8441733</ArticleId><ArticleId IdType="pubmed">34287905</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaira L.A., De Vito A., Deiana G., Pes C., Giovanditto F., Fiore V. Systemic inflammatory markers and psychophysical olfacory scores in coronavirus disease 2019 patients: Is there any correlation? J. Laryngol. Otol. 2021;135:723&#x2013;728. doi: 10.1017/S0022215121001651.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0022215121001651</ArticleId><ArticleId IdType="pmc">PMC8267245</ArticleId><ArticleId IdType="pubmed">34184623</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaira L.A., De Vito A., Deiana G., Pes C., Giovanditto F., Fiore V., Lechien J.R., Le Bon S.-D., Saussez S., Madeddu G., et al. Correlations between IL-6 serum level and olfactory dysfunction severity in COVID-19 patients: A preliminary study. Eur. Arch. Oto-Rhino-Laryngol. 2021:1&#x2013;6. doi: 10.1007/s00405-021-06868-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00405-021-06868-5</ArticleId><ArticleId IdType="pmc">PMC8117453</ArticleId><ArticleId IdType="pubmed">33983525</ArticleId></ArticleIdList></Reference><Reference><Citation>Amadu A.M., Vaira L.A., Lechien J.R., Scaglione M., Saba L., Lampus M.L., Profili S.G., Le Bon S., Salzano G., Maglitto F., et al. Analysis of the correlations between the severity of lung involvement and olfactory psychophysical scores in coronavirus disease 2019 (COVID-19) patients. Int. Forum Allergy Rhinol. 2021:1&#x2013;6. doi: 10.1002/alr.22869.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alr.22869</ArticleId><ArticleId IdType="pmc">PMC8426857</ArticleId><ArticleId IdType="pubmed">34296541</ArticleId></ArticleIdList></Reference><Reference><Citation>Saussez S., Sharma S., Thiriard A., Olislagers V., Duc I.V., Le Bon S., Khalife M., Hans S., De Riu G., Hopkins C., et al. Predictive factors of smell recovery in a clinical series of 288 coronavirus disease 2019 patients with olfactory dysfunction. Eur. J. Neurol. 2021;28:3702&#x2013;3711. doi: 10.1111/ene.14994.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.14994</ArticleId><ArticleId IdType="pmc">PMC8444937</ArticleId><ArticleId IdType="pubmed">34157187</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaira L.A., Lechien J.R., De Riu G., Saussez S. Chemosensory dysfunction in COVID-19: Is there really a correlation with viral load? Am. J. Otolaryngol. 2021;42:103037. doi: 10.1016/j.amjoto.2021.103037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjoto.2021.103037</ArticleId><ArticleId IdType="pmc">PMC8046703</ArticleId><ArticleId IdType="pubmed">33875304</ArticleId></ArticleIdList></Reference><Reference><Citation>Huart C., Philpott C.M., Altundag A., Alexander W., Fjaeldstad A.W., Frasnelli J. Systemic corticosteroids in coro-navirus disease 2019 (COVID-19)-related smell dysfunction: An international view. Int. Forum Allergy Rhinol. 2021;11:1041&#x2013;1046. doi: 10.1002/alr.22788.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alr.22788</ArticleId><ArticleId IdType="pmc">PMC8251281</ArticleId><ArticleId IdType="pubmed">33728824</ArticleId></ArticleIdList></Reference><Reference><Citation>Hopkins C., Alanin M., Philpott C., Harries P., Whitcroft K., Qureishi A., Anari S., Ramakrishnan Y., Sama A., Davies E., et al. Management of new onset loss of sense of smell during the COVID-19 pandemic - BRS Consensus Guidelines. Clin. Otolaryngol. 2021;46:16&#x2013;22. doi: 10.1111/coa.13636.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/coa.13636</ArticleId><ArticleId IdType="pmc">PMC7461026</ArticleId><ArticleId IdType="pubmed">32854169</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaira L., Hopkins C., Petrocelli M., Lechien J., Cutrupi S., Salzano G., Chiesa-Estomba C., Saussez S., De Riu G. Efficacy of corticosteroid therapy in the treatment of long- lasting olfactory disorders in COVID-19 patients. Rhinol. J. 2021;59:21&#x2013;25. doi: 10.4193/Rhin20.515.</Citation><ArticleIdList><ArticleId IdType="doi">10.4193/Rhin20.515</ArticleId><ArticleId IdType="pubmed">33290446</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitcroft K.L., Hummel T. Olfactory dysfunction in COVID-19: Diagnosis and management. JAMA. 2020;323:2512&#x2013;2514. doi: 10.1001/jama.2020.8391.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.8391</ArticleId><ArticleId IdType="pubmed">32432682</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaira L.A., Lechien J.R., Dore S., Boccaletti R., Saussez S., De Riu G. Specific Therapy of Olfactory Disorders in COVID-19 Patients is Essential for the Prevention of Long-term Dysfunction. Indian J. Otolaryngol. Head Neck Surg. 2021:1&#x2013;2. doi: 10.1007/s12070-021-02818-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12070-021-02818-z</ArticleId><ArticleId IdType="pmc">PMC8380412</ArticleId><ArticleId IdType="pubmed">34458129</ArticleId></ArticleIdList></Reference><Reference><Citation>Saussez S., Vaira L.A., Chiesa-Estomba C.M., Le Bon S.D., Horoi M., Deiana G., Petrocelli M., Boelpaep P., Salzano G., Khalife M., et al. Short-Term Efficacy and Safety of Oral and Nasal Corticosteroids in COVID-19 Patients with Olfactory Dysfunction: A European Multicenter Study. Pathogens. 2021;10:698. doi: 10.3390/pathogens10060698.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens10060698</ArticleId><ArticleId IdType="pmc">PMC8228154</ArticleId><ArticleId IdType="pubmed">34199734</ArticleId></ArticleIdList></Reference><Reference><Citation>Lechien J.R., Hoch C.C., Vaira L.A., Saussez S. The interest of fluticasone nasal spray in COVID-19 related anosmia is still not demonstrated. Am. J. Otolaryngol. 2021;42:103008. doi: 10.1016/j.amjoto.2021.103008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjoto.2021.103008</ArticleId><ArticleId IdType="pmc">PMC7987581</ArticleId><ArticleId IdType="pubmed">33810883</ArticleId></ArticleIdList></Reference><Reference><Citation>Skapinakis P., Lewis G., Mavreas V. Unexplained Fatigue Syndromes in a Multinational Primary Care Sample: Specificity of Definition and Prevalence and Distinctiveness from Depression and Generalized Anxiety. Am. J. Psychiatry. 2003;160:785&#x2013;787. doi: 10.1176/appi.ajp.160.4.785.</Citation><ArticleIdList><ArticleId IdType="doi">10.1176/appi.ajp.160.4.785</ArticleId><ArticleId IdType="pubmed">12668371</ArticleId></ArticleIdList></Reference><Reference><Citation>Cook E., Kelly C., Watson D., Hopkins C. Parosmia is prevalent and persistent amongst those with COVID-19 olfactory dysfunction. Rhinol. J. 2021;59:222&#x2013;224. doi: 10.4193/Rhin20.532.</Citation><ArticleIdList><ArticleId IdType="doi">10.4193/Rhin20.532</ArticleId><ArticleId IdType="pubmed">33377890</ArticleId></ArticleIdList></Reference><Reference><Citation>Parker J.K., Kelly C.E., Gane S.B. Molecular mechanism of parosmia. medRxiv. 2021 doi: 10.1101/2021.02.05.21251085.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.02.05.21251085</ArticleId></ArticleIdList></Reference><Reference><Citation>Croy I., Nordin S., Hummel T. Olfactory Disorders and Quality of Life&#x2014;An Updated Review. Chem. Senses. 2014;39:185&#x2013;194. doi: 10.1093/chemse/bjt072.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/chemse/bjt072</ArticleId><ArticleId IdType="pubmed">24429163</ArticleId></ArticleIdList></Reference><Reference><Citation>Lacson E., Jr., Xu J., Lin S.F., Dean S.G., Lazarus J.M., Hakim R.M. A comparison of SF-36 and SF-12 composite scores and subsequent hospitalization and mortality risks in long-term dialysis patients. Clin. J. Am. Soc. Nephrol. 2010;5:252&#x2013;260. doi: 10.2215/CJN.07231009.</Citation><ArticleIdList><ArticleId IdType="doi">10.2215/CJN.07231009</ArticleId><ArticleId IdType="pmc">PMC2827595</ArticleId><ArticleId IdType="pubmed">20019120</ArticleId></ArticleIdList></Reference><Reference><Citation>De Smedt D., Clays E., Annemans L., De Bacquer D. EQ-5D Versus SF-12 in Coronary Patients: Are They Interchangeable? Value Health. 2014;17:84&#x2013;89. doi: 10.1016/j.jval.2013.10.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jval.2013.10.010</ArticleId><ArticleId IdType="pubmed">24438721</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdullah N.N., Idris I.B., Shamsuddin K. Health-related quality of life in Malaysian gastrointestinal cancer patients and their family caregivers&#x2014;a comparison study. Support. Care Cancer. 2020;28:1891&#x2013;1899. doi: 10.1007/s00520-019-05007-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00520-019-05007-5</ArticleId><ArticleId IdType="pubmed">31359181</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu D., Besser G., Prem B., Speth M., Sedaghat A., Mueller C. Individual importance of olfaction decreases with duration of smell loss. Rhinol. J. 2021;59:32&#x2013;39. doi: 10.4193/Rhin20.196.</Citation><ArticleIdList><ArticleId IdType="doi">10.4193/Rhin20.196</ArticleId><ArticleId IdType="pubmed">32926009</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoskison E.E. Olfaction, pheromones and life. J. Laryngol. Otol. 2013;127:1156&#x2013;1159. doi: 10.1017/S0022215113002545.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0022215113002545</ArticleId><ArticleId IdType="pubmed">24280062</ArticleId></ArticleIdList></Reference><Reference><Citation>Pierron D., Pereda-Loth V., Mantel M., Moranges M., Bignon E., Alva O., Kabous J., Heiske M., Pacalon J., David R., et al. Smell and taste changes are early indicators of the COVID-19 pandemic and political decision effectiveness. Nat. Commun. 2020;11:5152. doi: 10.1038/s41467-020-18963-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-18963-y</ArticleId><ArticleId IdType="pmc">PMC7560893</ArticleId><ArticleId IdType="pubmed">33056983</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazzatenta A., Neri G., D&#x2019;Ardes D., De Luca C., Marinari S., Porreca E., Cipollone F., Vecchiet J., Falcicchia C., Panichi V., et al. Smell and Taste in Severe COVID-19: Self-Reported vs. Testing. Front. Med. 2020;7:589409. doi: 10.3389/fmed.2020.589409.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2020.589409</ArticleId><ArticleId IdType="pmc">PMC7745760</ArticleId><ArticleId IdType="pubmed">33344476</ArticleId></ArticleIdList></Reference><Reference><Citation>Lechien J.R., Saussez S., Maniaci A., Vaira L.A. The study of recovery rates of COVID-19 olfactory and gustatory dysfunc-tions requires psychophysical evaluations. Am. J. Otolaryngol. 2021;42:103168. doi: 10.1016/j.amjoto.2021.103168.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjoto.2021.103168</ArticleId><ArticleId IdType="pmc">PMC8320430</ArticleId><ArticleId IdType="pubmed">34339959</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaira L.A., Deiana G., Fois A.G., Pirina P., Madeddu G., De Vito A., Babudieri S., Petrocelli M., Serra A., Bussu F., et al. Objective evaluation of anosmia and ageusia in COVID-19 patients: Single-center experience on 72 cases. Head Neck. 2020;42:1252&#x2013;1258. doi: 10.1002/hed.26204.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hed.26204</ArticleId><ArticleId IdType="pmc">PMC7267244</ArticleId><ArticleId IdType="pubmed">32342566</ArticleId></ArticleIdList></Reference><Reference><Citation>Coughlin S.S. Recall bias in epidemiologic studies. J. Clin. Epidemiol. 1990;43:87&#x2013;91. doi: 10.1016/0895-4356(90)90060-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0895-4356(90)90060-3</ArticleId><ArticleId IdType="pubmed">2319285</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>